Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II study.
de la Haba-Rodriguez, Juan
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II study. [electronic resource] - Clinical breast cancer Aug 2010 - 313-7 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1938-0666
10.3816/CBC.2010.n.041 doi
Aged
Androstadienes--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Disease-Free Survival
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Kaplan-Meier Estimate
Middle Aged
Postmenopause
Treatment Outcome
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II study. [electronic resource] - Clinical breast cancer Aug 2010 - 313-7 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1938-0666
10.3816/CBC.2010.n.041 doi
Aged
Androstadienes--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Disease-Free Survival
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Kaplan-Meier Estimate
Middle Aged
Postmenopause
Treatment Outcome